[161Tb]Tb-DOTA-chCE7

N/A

Report date: 2025/10/21 17:57:20

Base Information

Drug Name[161Tb]Tb-DOTA-chCE7

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Terbium > 161TbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionNeural cell adhesion molecule L1 modulators

TargetsNeural cell adhesion molecule L1

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Basel

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Basel

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A